2009
DOI: 10.1292/jvms.71.177
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Consequence of Congenital Asplenia Caused by the Dominant hemimelia Mutation in Mice

Abstract: ABSTRACT. The potential roles of the spleen in lipid metabolism have been debated for the last 2 decades. Although there are some discrepancies among investigations, they are in agreement on the point that the spleen has roles in lipid metabolism. In the present study, role of the spleen in lipid metabolism was investigated by use of a hereditary asplenic mouse strain carrying a Dominant hemimelia (Dh) mutation. In studies on females, asplenic mice (Dh/+) had significantly lower plasma high-density lipoprotein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
2
2

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…Based on the studies of Y-consomic mice, the lineage effect was not due to influence by Chr Y [23, 24]. Furthermore, because we observed the lineage effect in the comparison between F 1 females, we concluded that the effect of Chr Y on plasma lipid concentrations is extremely small or nonexistent.…”
Section: Discussionmentioning
confidence: 59%
“…Based on the studies of Y-consomic mice, the lineage effect was not due to influence by Chr Y [23, 24]. Furthermore, because we observed the lineage effect in the comparison between F 1 females, we concluded that the effect of Chr Y on plasma lipid concentrations is extremely small or nonexistent.…”
Section: Discussionmentioning
confidence: 59%
“…Because Y chromosome and mitochondrial substitutions are made so readily, they have been used for many years to study a variety of traits in many strain combinations (for recent examples, see Barrick et al 2009; Llamas et al 2009; Suto 2009; Nelson et al 2010; Hines et al 2011; Case et al 2012; Kotarska and Styrna 2012). In other instances, an autosomal CSS was made specifically to verify and in some cases localize QTLs with crosses and congenic strains (see, for example, Matin et al 1999; Ochiai et al 2003; Hollis-Moffatt et al 2005; Kumazawa et al 2007; Wang et al 2010; Anderson et al 2009; Trammell et al 2012).…”
Section: Making Csssmentioning
confidence: 99%
“…Other examples of studies based on congenic–consomic strains include modifiers of the spectrum and latency of spontaneous tumors in p53-deficient CSS-19 mice (Ochiai et al 2003), the impact of apslenia on lipid metabolism in CSS-Y strains with the dominant hemimelia Dh mutation (Suto 2009), and modifiers of tumor resistance in NF1-, p53-deficient mice (Barrick et al 2009). …”
Section: Strategies To Locate Qtlsmentioning
confidence: 99%